Loading clinical trials...
Loading clinical trials...
A Phase IIa Study To Investigate The Effects of AER 001 on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration.
Conditions
Interventions
AER 001
placebo
Locations
1
United Kingdom
Guy's Drug Research Unit, Quintiles, Ltd.
6 Newcomen Street London, London, United Kingdom
Start Date
January 1, 2005
Completion Date
May 1, 2005
Last Updated
September 26, 2007
NCT05008965
NCT04699604
NCT01536522
NCT06151938
NCT05186025
NCT06438757
Lead Sponsor
Aerovance, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions